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Objective: The authors investigated the relationship of cognitive and coping characteristics
to stressful life events at the time of relapse in patients with recent-onset paranoid schizophre-
nia. Method: Over 6 years, the authors collected data on 41 schizophrenic outpatients aged
18–28 years at recruitment. The patients were rated prospectively every 2 weeks with the Brief
Psychiatric Rating Scale, Scale for the Assessment of Negative Symptoms, Scale for the As-
sessment of Positive Symptoms, Global Assessment of Functioning Scale, and life events meas-
ures. The Frankfurt Questionnaire of Complaints was used to analyze subjective complaints
regarding cognitive and coping abilities. The P300 auditory event-related potential was mea-
sured at recruitment to provide an index of information-processing capability. Results: Pa-
tients without severe life events during the 1 month before relapse had a smaller P300, more
subjective complaints, and less coping capacity than did relapsed schizophrenic subjects who
had severe life events in the month before relapse. Conclusions: Relapses in subjects without
severe life events were associated with fewer cognitive resources and less coping ability. Pa-
tients with normal P300 and adequate coping resources seemed to be able to deal better with
stressful life events.
 (Am J Psychiatry 1997; 154:792–798)
T he role of independent life events in schizophrenicrelapses has been well documented in both retro-
spective (1, 2) and prospective (3, 4) studies. However,
what deserves further consideration is that at least 50%
of the instances of schizophrenic relapse occur without
any increase in major life events in the preceding 1-
month period (4, 5), suggesting that these patients may
experience acute accentuations of vulnerability to re-
lapse as a result of natural oscillation in their biological
systems (4). To our knowledge, to date there have been
no investigations relating the cognitive characteristics
of schizophrenic subjects to the level of stress at the time
of relapse, and the aim of the present study was to start
to fill this gap.
Schizophrenic vulnerability (comprising, for exam-
ple, certain cognitive dysfunctions and specific coping
limitations) may be associated with sensitivity to so-
cioenvironmental stress factors that lift the individual’s
susceptibility over the threshold beyond which an exac-
erbation of psychotic symptoms or a relapse can be ex-
pected (6, 7).
One serious difficulty in carrying out this kind of
study relates to the process of assessing and determin-
ing the degree of reliability of the recollection of life
events during the course of the disease. To avoid the
common biases that can occur in this kind of research,
a series of measures were adopted: prospective research
with follow-up analysis, schizophrenic subtyping (in
order to avoid producing results that cannot be ex-
tended to an entire schizophrenic subpopulation), the
use of appropriate criteria to define relapse, and the use
of appropriate instruments for the assessment of stress-
ful life events, such as Brown and Harris’s Life Events
and Difficulty Schedule (8), which was conducted by a
trained expert.
In their ongoing longitudinal study of developmental
processes in schizophrenia, Nuechterlein et al. (5, 9) fo-
cused on several information-processing neuropsycho-
logical and neurophysiological indexes (“stable vulner-
ability indicators”), but they did not consider each
subject’s coping strategies and the level of subjective ex-
periences, nor did they consider the P300 event-related
potential, which is one of the most reliable indexes of
information-processing dysfunction (10–12).
Moreover, lower rates of relapse (13, 14) have been
associated with a small P300 amplitude in schizo-
phrenic patients.
We may hypothesize that this susceptibility to stress
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is the result of both information-processing abnormali-
ties and maladaptive coping mechanisms and strategies
used by the patient (15). In fact, it is well known that
schizophrenic subjects attempt to deal with certain
consequences of vulnerability by using self-protective
coping strategies, with varying degrees of success. The
effectiveness or otherwise of such compensatory strate-
gies may play an important role in preventing, or failing
to prevent, a psychotic breakdown (16).
To our knowledge, this is the first prospective study
to examine the correlation of cognitive and coping
characteristics with stressful life events before relapse in
a homogeneous schizophrenic study group. Although
possible information-processing abnormalities are rela-
tively accessible through neurophysiological tech-
niques, in investigating coping we had to venture be-
yond the “shadow line” of information processing, to
include an assessment of subjective cognitive strategies.
METHOD
Subjects
The initial study group consisted of 53 outpatients recruited, after
giving written informed consent, on a rolling basis at the Institute for
Neurosciences in Florence beginning in March 1990 (17). From the
initial group, 41 right-handed outpatients (31 male, 10 female) were
considered; they fulfilled the DSM-III-R criteria and Research Diag-
nostic Criteria (18) for schizophrenic disorder, paranoid type. Their
mean age was 23.7 years (SD=3.6, range=18–28), and they had an
initial onset of psychosis no more than 30 months before recruitment.
The mean duration of illness at the time of recruitment was 1.7 years
(SD=1.2), and the mean number of weeks of prior hospitalization was
10.2 (SD=4.4). The mean educational level of the patients was 10.9
years (SD=2.8). The exclusion criteria were signs of tardive dyskine-
sia, concomitant medical diseases, substance abuse (investigated
through biological tests when suspected in the clinical interview), and
previous ECT. The patients’ IQs, as measured by the WAIS, were
normal. No patient received lithium or carbamazepine, and all pa-
tients were receiving neuroleptic treatment during follow-up. At the
time of neurophysiological and clinical investigation the mean dose in
chlorpromazine equivalents per day was 204.7 mg (SD=97.4); at re-
lapse the mean neuroleptic dose was 211.3 mg. The comparison
group consisted of 41 right-handed age- and sex-matched healthy vol-
unteers recruited from the community (mean age=24.9 years, SD=
4.3). None had a personal or family history of psychiatric disorders,
relevant medical diseases, or drug abuse.
Clinical Evaluations
Clinical ratings. Clinical assessment was conducted by using the
Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of
Negative Symptoms (SANS) and the Scale for the Assessment of Posi-
tive Symptoms (SAPS) (19), and the Global Assessment of Function-
ing Scale (DSM-III-R). Every 2 weeks after recruitment, an experi-
enced psychiatrist rated the patient’s clinical state with these
measures. The raters were blind to the results of the psychophysi-
ological analysis. The method of Ventura et al. (4) was used to deter-
mine psychotic relapse and exacerbation, and these two categories
were combined in the analyses. Scores on three BPRS subscales (un-
usual thought content, hallucinations, conceptual disorganization)
were considered in order to define the following.
1. Psychotic relapse: a rating of 6 or 7 on any of the three scales
after the patient had been in remission (score of 3 or below) for at
least 1 month.
2. Major psychotic exacerbation following a state of remission: a
rating of 5 plus an increase of 2 points on one of the other two scales,
or a rating of 5 on any of the three scales for more than two consecu-
tive 2-week BPRS ratings.
3. Major psychotic exacerbation following a state of persisting psy-
chotic symptoms: an increase of 2 or more points to a scale rating of
6 or 7, or a 1-point increase on any scale to a rating of 6 or 7 plus an
accompanying 2-point increase on one of the other two scales.
Assessment of life events. Life events were assessed in the patient
group every 2 weeks after recruitment by using the open-ended ques-
tions of Brown and Harris (8) to determine whether an event was of
sufficient magnitude or associated with sufficient change in role status
to be categorized as a life event. The healthy subjects were assessed
for life events at recruitment but not during follow-up. This evalu-
ation was conducted by a certified psychiatrist (S.P.), following spe-
cific training from Brown and Harris, using the procedure for collect-
ing and rating life events described elsewhere by Faravelli and Pallanti
(20). The interviewers were aware of the patient or comparison status
of the subjects, but the assessor was not: he received randomly mixed
reports and was not involved in the interviews. Any element that
could permit identification was omitted. A 4-point scale was used to
rate the threat the average person would see in the event: 1=marked
threat, 2=moderate threat, 3=mild threat, 4=no threat.
The normative list of life events of Paykel et al. (21) was also used
in order to provide measurable indexes of stressful events (number of
events, weighted scores for all events, subjects with at least one severe
event) in the 3 months preceding relapse. Ratings of 1 and 2 on the
Brown and Harris assessment and the 20th-ranked event on the scale
of Paykel et al. (“loss of personally valuable object”) were considered
the cutoff points to distinguish severe from nonsevere events, and
events were classified as “dependent” (i.e., under the control of the
subject or related to the illness) or “independent” (i.e., unexpected
and not determined by the subject’s behavior) (22). For instance, an
event such as “sudden stroke of father” was considered unlikely to be
determined by the subject and was thus assessed as independent. On
the other hand, events such as “loss of job because of absenteeism”
were considered dependent, since they were possibly secondary to
disordered behavior on the part of the subject.
Cognitive Evaluations
Objective: P300 testing. At recruitment the P300 auditory evoked
potential (P3b component) in the patients and normal subjects was
obtained by means of a simple “oddball” paradigm. Two successive
series of randomly intermixed tones (1000 Hz, overall probability
85%; 2000 Hz, probability 15%) were delivered binaurally through
earphones at a rate of one tone (70-dB sound level, 50-msec duration)
every 1.1 seconds. The subjects were required to keep a mental count
of the rare tones and to report the number at the end of each series.
The responses were recorded (filter bandpass: 0.1–100 Hz) from
scalp Ag/AgCl Fz, Cz, and Pz electrodes, all referring to linked mas-
toids. The Fz electrode registrations were excluded from the statistical
analyses because of a generalized smaller amplitude of the P3b com-
ponent that is less useful in comparing groups and because of the
desire to minimize the risk of ocular artifacts on the tracks. Eye move-
ments were monitored through electrodes on the nasion and on the
left zygomatic bone. The responses to the frequent (N=100) and rare
(N=28–30) tones were averaged separately and stored on flexible
diskettes for off-line analysis. Trials containing eye movement arti-
facts of 100 µV or more were automatically rejected. The peak la-
tency and peak-to-peak amplitude of P3b in response to the rare tone
were measured in all the electrodes (figure 1).
Subjective: experienced disturbances and coping. The Frankfurt
Questionnaire of Complaints (23, 24) is a measure for self-evaluation
of subjective disturbing experiences of cognitive impairment. It was
used with both the patients and healthy subjects. It consists of 98
statements (yes/no answers) organized according to four dimensions
of the disturbance, as established by Süllwold and Huber (23) from
factor analysis: 1) disorders of normally automatic skills, 2) percep-
tual disorders, 3) depression/anhedonia, and 4) stimulus overload.
To investigate coping, we extracted a short 20-item version of the
questionnaire, with five items per dimension, that satisfied the criteria
of a high loading on one of the dimensional factors, and it was used
according to the method applied by Wiedl and Schöttner (25). In a
subsequent semistandardized interview, the patients were asked what
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strategies helped them to cope with the basic disturbances covered in
the questionnaire.
Questions were formulated from a list given to the interviewer
(e.g., “How do you cope with this situation?” and “How do you
handle or manage this problem?”). This procedure was applied for
each of the 20 items in the shortened Frankfurt Questionnaire of
Complaints to which the subject responded affirmatively. The pa-
tients were also asked to rate on a 5-point scale how effective their
efforts were in coping with the respective stresses. The interviewer’s
written reports on the patients’ answers were also evaluated by two
expert psychiatrists separately, to identify the directivity and the level
of coping strategies. For each basic symptom, the coping efforts were
classified as “problem-centered” (directly aimed at modifying or
eliminating the source of interference) or “non-problem-centered”
(maintaining distance from whatever is experienced as stressful, i.e.,
withdrawal, avoidance, suppression, or other ineffective cognitive
coping reaction), according to the method adopted by Brenner et al.
(26). Three further types of coping strategy were considered: behav-
ioral (externally observable actions), cognitive (inner coping proc-
esses), and emotional (affective reactions). Assessment of the clinical
ratings and coping characterization was conducted by three experi-
enced psychiatrists including S.P. and L.Q.). Interrater reliability was
assessed every 12 months and consistently ranged between 0.75 and
0.90 (Cohen’s kappa). Concordance on the Frankfurt Questionnaire
of Complaints, determined for a 10-patient randomly selected sub-
group, was never less than 79%.
Statistical Analysis
One-way analysis of variance (ANOVA), ANOVA for repeated
measures, the paired t test, and the chi-square test were performed
where appropriate to assess the significance of differences between
groups, with alpha set at p<0.05, two-tailed. The data were analyzed
by using the SPSS/PC package (27), running on a 33-MHz 486 per-
sonal computer.
RESULTS
Of the initial 53 patients, 12 (22.6%) were excluded
from the analysis: five dropped out and seven did not
relapse during the follow-up period (mean=26.3 weeks,
SD=11.2).
At the time of relapse, the mean clinical scores were
as follows: BPRS, 51.2 (SD=7.4); SAPS (sum of global
scores), 13.5 (SD=2.1); and SANS (sum of global
scores), 9.8 (SD=3.8).
The entire group was analyzed for stressful life events
in the 3 months preceding relapse. The mean score on
the Paykel life events scale for the schizophrenic pa-
tients was 20.9 (SD=5.0), while the mean score for in-
dependent life events in the same period was 13.1 (SD=
4.5). As shown in table 1, the magnitude of stressful life
events, especially independent ones, increased in the
13 weeks before relapse, but the scores increased espe-
cially during the 4 weeks before the psychotic episodes
(table 1).
For further analysis, two subgroups were formed
from the relapsed schizophrenic patients: the 25 pa-
tients (61.0%) who had at least one severe independent
life event (Brown and Harris rating of 1 or 2; rank of
1–20 on scale of Paykel et al.) in the 1 month before
relapse and the 16 patients who did not (39.0%). Table
2 compares the demographic, neurophysiological, and
clinical characteristics of the two subgroups.
No differences were found between the two sub-
groups in terms of age, sex, and clinical state (BPRS,
SANS, and SAPS scores). Patients who had had at least
one severe independent life event in the 1 month before
relapse had a significantly higher educational level and
global functioning score in the last year (table 2), a
markedly and significantly higher P300 (P3b compo-
nent) amplitude (table 3), and a nonsignificantly lower
P300 latency (table 3).
The schizophrenic patients showed significantly longer
P300 latencies and smaller amplitudes than the healthy
subjects (table 3). However, the patients who had at least
one severe independent life event in the month before re-
TABLE 1. Magnitude of Life Events in Three 1-Month Periods Before Relapse for 41 Schizophrenic Patients
Score on Scale of Paykel et al. (21)
ANOVA for
90–61 Days
Before Relapse
60–31 Days
Before Relapse
30–1 Days
Before Relapse
Repeated Measures
(df=2, 40)
Type of Life Event Mean SD Mean SD Mean SD F p
All 17.0 9.3 18.6 8.5 26.9a 12.9 10.63 <0.001
Independentb 10.4 5.1 11.7 7.7 18.2c  9.2 12.59 <0.001
aSignificantly different from preceding 1-month period (paired t test; t=3.21, df=40, p<0.01).
bUnexpected and not determined by the patient’s behavior.
cSignificantly different from preceding 1-month period (paired t test; t=3.16, df=40, p<0.01).
FIGURE 1. P300 Auditory Evoked Potential (Cz, Pz) and Electro-
Oculogram (EOG) for (A) a Healthy Subject and (B) a Relapsed
Schizophrenic Patient Who Did Not Have Any Severe Independenta
Life Events in the 1 Month Before Relapse
aUnexpected and not determined by the patient’s behavior.
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lapse showed less difference
from the healthy subjects in
P300 latencies than did the
patients without severe life
events, and they showed no
significant difference from
the healthy subjects in Cz-
electrode P3b performance.
Table 4 shows subgroup
and overall scores on the
Frankfurt Questionnaire of
Complaints, the question-
naire used to assess subjec-
tive disturbances. The pa-
tients who did not have any
severe independent life
events in the 1 month before
relapse had higher scores on
most measures than the pa-
tients who had at least one
severe independent life event
during this period; the differ-
ence was especially great for
the fourth factorial dimension of basic disturbances (ex-
ternal and internal overstimulation).
The comparison subjects had a much lower total score
on the Frankfurt Questionnaire of Complaints (mean=
6.4, SD=4.9) than did the patients (mean=46.6, SD=16.3)
(t=15.11, df corrected for unequal variances=47,
p<0.001), and the scores on the subscales were also much
lower than those of the patients (data not shown).
The reduced version of the Frankfurt Questionnaire
of Complaints (20 high-loading items) was then ex-
tracted, to permit easier investigation of coping mecha-
nisms; the results are shown in table 5. The patients
who had at least one severe independent life event in the
1 month before relapse had a significantly higher rate
of problem-centered coping strategies than did the pa-
tients who did not have any severe independent life
events, and they showed significantly more effective be-
havioral and cognitive coping. In particular, the pa-
tients who did not have any severe independent life
events in the month before relapse reacted with behav-
ioral coping to basic disturbances in 60.9% of the situ-
ations but exhibited a high occurrence of failure in be-
havioral coping directivity (67.0% of all behavioral
coping). Globally, they showed a predominance of
non-problem-centered coping, whereas the patients
who did experience severe life events before relapse
used non-problem-centered coping in fewer than one-
half of the instances. No significant differences were
found in emotional coping responses between the two
subgroups.
TABLE 2. Characteristics of Relapsed Schizophrenic Patients With and Without at Least One Severe Independenta Life Event in the 1 Month
Before Relapse
Baseline Characteristic
Patients With
Severe Life
Events (N=25)
Patients Without
Severe Life
Events (N=16) Analysis
Total Group
(N=41)
N N χ2 (df=1) N
Sex 0.08 
Female  8  5 13
Male 17 11 28
Mean SD Mean SD F (df=1, 40) Mean SD
Age (years) 24.2  4.1 22.6  3.4 1.69 23.7  3.6
Educational level (years) 11.6  2.8  9.7  2.7 4.58* 10.9  2.8
Score on Global Assessment of Functioning
Scale (for previous year) 61.8 12.9 51.4 13.6 6.06* 57.7 13.2
BPRS total score 31.8  6.5 35.2  8.3 2.20 33.1  7.2
SAPS score (sum of global scores)  4.6  1.9  5.2  2.1 0.75  4.8  2.0
SANS score (sum of global scores)  8.8  2.7  9.2  2.5 0.17  9.0  2.6
aUnexpected and not determined by the patient’s behavior.
*p<0.05.
TABLE 3. Amplitude and Latency of P300 Auditory Evoked Potential for Relapsed Schizophrenic
Patients With and Without at Least One Severe Independenta Life Event in the 1 Month Before Relapse
and for Healthy Subjects
P300 Measure
Schizophrenic Patients
With Severe
Life Events
(N=25)
Without Severe
Life Events
(N=16) Total (N=41)
Healthy
Subjects
(N=41)
Mean SD Mean SD Mean SD Mean SD
Amplitude (µV)
Cz  12.7b  4.6   7.5c  3.2  10.6d  4.1  15.5  6.5
Pz  13.4e  5.1   9.4c  4.6  11.9d  4.9  16.9  6.2
Latency (msec)
Cz 344.1f 45.4 367.3c 49.0 353.1g 46.8 317.2 25.0
Pz 348.3f 45.7 368.7c 47.2 356.3g 46.3 319.4 25.8
aUnexpected and not determined by the patient’s behavior.
bSignificantly different from patients without severe life events (one-way ANOVA; p<0.0001, df=1, 40).
cSignificantly different from healthy subjects (one-way ANOVA; p<0.0001, df=1, 56).
dSignificantly different from healthy subjects (one-way ANOVA; p<0.01, df=1, 81).
eSignificantly different from patients without severe life events (p<0.05, df=1, 40) and from healthy
subjects (p<0.05, df=1, 65) (one-way ANOVA).
fSignificantly different from healthy subjects (one-way ANOVA; p<0.01, df=1, 56).
gSignificantly different from healthy subjects (one-way ANOVA; p<0.0001, df=1, 81).
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DISCUSSION
The main finding of the present study is that schizo-
phrenic patients who relapsed without the occurrence
of severe stressful life events in the preceding month
manifested a significantly lower P300 amplitude and
significantly more complaints of subjective cognitive
dysfunction but also more dysfunctional coping strate-
gies than schizophrenic patients who had at least one
severe independent life event in the 1 month before re-
lapse.
The percentages of patients who relapsed with
(61.0%) and without (39.0%) severe life events are
similar to previous results from both retrospective (2)
and prospective (4, 28, 29) studies.
The clinical characteristics of the study group (outpa-
tients, young age, recent onset of the disease, psycho-
tropic drug use), the diagnostic subtype (paranoid), and
the relatively good social adaptation should enable us to
avoid the “floor effect” related to social disconnection
(which involves a reduction of social events) and to per-
mit assessment of intragroup discrimination reliability.
The present findings lend support to our working hy-
pothesis that differences in how patients deal with life
events may be mediated by complex cognitive and cop-
ing capacities and that relapses in patients possessing
better-preserved information-processing ability and
more-effective coping strategies (while taking psycho-
tropic medication) could be significantly related to ad-
ditional stress resulting from life events.
P300 abnormalities have been related to clinical char-
acteristics, such as residual symptoms (30), positive
(31) or negative (32, 33) symptoms, thought disorder
scores (34), higher risk for tardive dyskinesia (14), and
poor outcome (13, 14), but the data from the studies on
outcome are controversial. Hegerl et al. (14) reported a
TABLE 4. Subjective Cognitive Disturbances in Relapsed Schizophrenic Patients With and Without at Least One Severe Independenta Life
Event in the 1 Month Before Relapse
Measure From the Frankfurt Questionnaire
of Complaints (23, 24)
Score (number of affirmative answers)
Patients With
Severe Life
Events (N=25)
Patients Without
Severe Life
Events (N=16)
F (df=1, 40)
Score of Total
Group (N=41)
Mean SD Mean SD Mean SD
Total (98 statements) 41.6 14.7 54.3 15.2  7.06* 46.6 16.3
Automatic skills (22 statements) 11.2  5.4 15.0  6.2  4.28* 12.7  5.7
Perceptual disturbance (30 statements) 10.0  5.1 11.9  5.9  1.14  10.7  5.6
Anhedonia (27 statements) 16.2  5.0 15.2  4.1  0.37  15.8  4.7
Overstimulation (18 statements)  9.0  4.2 15.6  5.7 18.02** 11.6  4.7
aUnexpected and not determined by the patient’s behavior.
*p<0.05. **p<0.01.
TABLE 5. Coping Efforts by Relapsed Schizophrenic Patients With (N=25) and Without (N=16) at Least One Severe Independenta Life Event
in the 1 Month Before Relapse
Coping Strategy and Directivity
of Copingb
Instances of Coping Strategy
χ2 (df=1)
Instances of
Coping Strategy
for Total Group
(380 coping
efforts)
Patients With
Severe Life
Events (201
coping efforts)
Patients Without
Severe Life
Events (179
coping efforts)
N % N % N %
Behavioral coping  7.50** 
Problem-centered  57 28.4  36 20.1  93 24.5
Non-problem-centered  52 25.9  73 40.8 125 32.9
Cognitive coping  5.64*  
Problem-centered  48 23.9  18 10.1  66 17.4
Non-problem-centered  18  9.0  20 11.2  38 10.0
Emotional coping  1.49   
Problem-centered  14  7.0  11  6.1  25  6.6
Non-problem-centered  12  6.0  21 11.7  33  8.7
Total 18.96***
Problem-centered coping 119 59.2  65 36.3 184 48.4
Non-problem-centered coping  82 40.8 114 63.7 196 51.6
aUnexpected and not determined by the patient’s behavior.
bProblem-centered coping was activity directly aimed at modifying or eliminating the source of interference. Non-problem-centered coping was
a reaction that maintained distance from whatever was experienced as stressful, i.e., withdrawal, avoidance, suppression, or other ineffective
cognitive coping reaction.
*p<0.05. **p<0.01. ***p<0.001.
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low relapse rate in a group of schizophrenic patients
with a small P300 amplitude and concluded that small
P300 amplitude could indicate a more chronic course
and an unfavorable outcome in these patients, a view in
line with a previous suggestion by Murray et al. (13).
However, the conclusion of Hegerl et al. is based on
results obtained from chronically ill schizophrenic pa-
tients (whose reports have low reliability) and, more-
over, is not entirely supported by the results themselves,
which lack statistical significance (the relapse rate
among patients with P300 amplitudes larger than 4.9
µV was 13 of 44, and the rate among patients whose
P300 amplitudes were smaller than 4.9 µV was seven
of 44). The use of unstandardized and nonspecific re-
lapse criteria such as “hospitalization” (mean number
of prior hospitalizations=3.1, range=1–16) has to be
considered another form of bias.
A limitation of the present study was that P300 was
assessed only in the recruitment stage. Assessment at
the time of relapse, although it might have been difficult
because of poor cooperation by patients in the record-
ing of event-related potentials, would be useful for the
evaluation of possible changes. As P300 changes have
been documented in association with clinical improve-
ment (35) resulting from neuroleptic treatment (36–
38), we cannot exclude the possibility that the patients’
good P300 performance and subsequent resistance to
stress may be effects of the treatment. However, this
does not undermine the importance of the research re-
sults; indeed, it highlights the importance of evaluating
cognitive features both in relation to the response to
neuroleptics and in the different phases because it
would provide information about a clinically homoge-
neous study group such as ours. In fact, there is evi-
dence that the P300 amplitude does not change signifi-
cantly after neuroleptic treatment (39, 40).
It remains to be seen whether small P300 amplitude
should be considered as a trait or a phase index of cog-
nitive susceptibility to stress.
While our schizophrenic patients did not differ from
the normal subjects in earlier phases of event-related
potentials, it would be interesting to focus on the char-
acteristics of the endogenous negativity through other
tasks, such as a simple response task and a discrimina-
tive response task (41), to permit a more specific evalu-
ation of cognitive processing.
In the present study patients who did not have any
severe independent life events in the 1 month before re-
lapse exhibited a higher rate of subjective complaints
(so-called basic symptoms) and a smaller capacity for
and less effectiveness of self-generated coping strategies
than patients who did have severe life events in the pre-
ceding month, and the patients without severe life
events also had a significantly smaller P300 amplitude.
A correlation between subjective experience of cogni-
tive disturbances and event-related potentials has al-
ready been reported: van den Bosch and Rozendaal (42)
found that a subjective disturbance score, not clinical
ratings, showed significant associations with psycho-
physiological measures (contingent negative variation,
reaction time). In contrast, our schizophrenic patients
who had at least one severe independent life event in the
1 month before relapse had normal P300 measures and
had a lower score for subjective complaints and greater
use of problem-centered coping strategies than patients
without severe life events.
The concept of coping corrects the image of the
schizophrenic patient as a person who is passive and
helpless in the face of his or her illness; in fact, a self-
perception of cognitive abnormalities leads the patient
to attempt to cope with his or her deficits (43).
It has also been proposed that life events have a
modulating role in the course of schizophrenic illness
(23, 29), but their weight in predicting relapse probably
depends to a certain extent on personal adaptive capa-
bilities and the effectiveness of coping strategies. Pa-
tients are likely to have fewer and less flexible personal
and social resources than most people with which to
cope with family tension or stressful events when they
arise. Thus, the role of stress in schizophrenic disorder
may involve not only exposure to somewhat greater lev-
els of stress but also limited coping resources.
In particular, complaints of hyperarousal/overstimula-
tion in our patients were associated with a small P3b am-
plitude. Moreover, the availability of problem-solving
coping mechanisms is a protective factor and enhances
tolerance to stress. We found that subjects with a higher
documented level of cognitive impairment had a higher
rate of non-problem-solving coping mechanisms.
Attempts at self-protection may be more or less effec-
tive in managing the various types of internal or exter-
nal strain. For instance, if certain instances of stress are
long-lasting or uncontrollable, coping strategies di-
rected at controlling these strains will probably fail and
lead to further stress (44).
Our results support the hypothesis that cognitive vul-
nerability (both objectively documentable and subjec-
tively experienced) enhances susceptibility to stressful
events and could be considered an index for relapses, at
least in a subgroup or phase of schizophrenic disorder.
Cognitive disturbances should be assessed in every thera-
peutic project and taken into account in the pharma-
cological “tailoring process” in order to improve the
management of the disorder. The analysis of the cogni-
tive characteristics of experience suggests not that the at-
tempt to venture beyond the “shadow line” is a danger-
ous plunge into the abyss but, rather, that it is both a
realistic and productive path to follow. Our finding that
more severe cognitive disturbance seems to be related to
enhanced susceptibility to stressful events and less-effec-
tive coping could constitute a rationale for treating cog-
nitive dysfunctions in schizophrenia and for attending to
patients’ subjective experience and coping strategies.
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